x



Share this page.

SOT Global Partners

The Society of Toxicology has established a special category for private, public, and not-for-profit organizations that wish to contribute to the success of the Society.

The SOT President of the Society, with the approval of the SOT Council, may on an annual basis invite any firm, association, corporation, institution, or subdivision thereof, to become an SOT Global Partner in support of the Society. SOT reviews the character of supporters and approves receiving funding from supporters. SOT reserves the right to refuse acceptance of funds from any organization whose goals, objectives, or past actions are deemed counterproductive to those of the Society. SOT does not accept contributions from tobacco companies, nor does it permit tobacco companies to be SOT Global Partners. Organizations interested in becoming an SOT Global Partner, should contact SOT Headquarters.

Open All
Close All
Why Support SOT
By becoming an SOT Global Partner, organizations are:
  • Supporting the premiere toxicology society in increasing the scientific impact of and advocating for the value of toxicology;
  • Contributing to the success of the largest scientific meeting in toxicology and attracting scientists at all stages of their careers from around the globe;
  • Promoting the importance of education and building for the future of toxicology; and
  • Encouraging activities aligned with the prediction and prevention of toxicity and disease.
Benefits of Partnership
By becoming an SOT Global Partner, organizations received the following benefits:
  • Access to member-restricted information on the SOT website.
  • Reduced rate for SOT Job Bank services.
  • Complimentary registration for SOT Annual Meeting and ToxExpo for one attendee.
  • Prominent listing on the SOT website, in the SOT Membership Directory, and Annual Meeting signage and materials, including the Preliminary Program and final Program.
  • Subscriptions to SOT publications, including the SOT’s journal, Toxicological Sciences, Annual Meeting Program and other materials, and the newsletter, Communiqué.
  • Complimentary room rental for one meeting at the SOT Annual Meeting and ToxExpo.
Current SOT Global Partners

AbbVie
North Chicago, IL

American Petroleum Institute
Washington, DC

AstraZeneca
Mecclesfield, UNITED KINGDOM

Bristol-Myers Squibb Company
Pennington, NJ

Celgene Corporation
Summit, NJ

Charles River
Wilmington, MA

Charles River Laboratories SA USA, Inc.
Ashland, OH

Chevron Corporation
San Ramon, CA

Covance Inc.
Madison, WI

CRC Press/Taylor & Francis Group
Boca Raton, FL

Dow Chemical Company
Midland, MI

Dow Corning Corporation
Midland, MI

Eli Lilly & Company
Indianapolis, IN

Envigo
East Millstone, UNITED STATES

ExxonMobil Biomedical Sciences, Inc.
Annandale, NJ

Genentech, Inc.
South San Francisco, CA

Gilead Sciences Inc
Foster City, AZ

Honeywell International, Inc.
Morris Plains, NJ

Janssen Pharmaceutical Companies of Johnson & Johnson
Raritan, NJ

MPI Research
Mattawan, MI

Organovo, Inc.
San Diego, CA

Oxford University Press
Oxford,

Pfizer, Inc.
Groton, CT

Procter & Gamble Company
Cincinnati, OH

Regeneron Pharmaceuticals, Inc.
Tarrytown, NY

Sanofi
Bridgewater, NJ

SNBL USA, Ltd.
Everett, WA

Syngenta Crop Protection, Inc.
Greensboro, NC

Takeda Pharmaceutical Company Limited
Cambridge, MA

The Colgate-Palmolive Company
Piscataway, NJ

The DuPont Haskell Global Centers for Health and Environmental Sciences
Newark, DE

Toxicology Excellence for Risk Assessment (TERA)
Cincinnati, OH

Western Slope Laboratory, LLC
Troy, MI

WuXi AppTec
Saint Paul, MN

XRpro Sciences, Inc.
Cambridge, MA





SOT reviews the character of supporters and approves receiving funding from supporters. SOT reserves the right to refuse acceptance of funds from any organization whose goals, objectives, or past actions are deemed counterproductive to those of the Society. SOT does not accept contributions from tobacco companies, nor does it permit tobacco companies to be SOT Global Partners.